Biosensor mouse lights up health and disease

October 6, 2017
Biosensor mouse lights up health and disease
A glow-in-the-dark breast tumour (green, blue and yellow) in living tissue, fed by blood vessels (red) and surrounded by dense collagen matrix (purple). Credit: Garvan Institute

Researchers from Sydney's Garvan Institute of Medical Research and the UK have developed a glow-in-the-dark "biosensor mouse" that gives a real-time readout of the rapidly changing "skeleton" within cells.

Using sophisticated , the researchers have watched as in the biosensor respond dynamically to their surrounding environment in living tissues – including bone and the immune system – and as the cell's skeleton is co-opted to drive breast and pancreatic cancers to spread.

"The biosensor mouse gives us unprecedented insight into how cells respond to the environment that surrounds them – both in normal tissues and in cancer," said the Garvan Institute's Associate Professor Paul Timpson, who co-led the study with Professor Kurt Anderson of the Francis Crick Institute, UK.

"Each of the cells in our body has its own tiny skeleton – and with the biosensor, we can see what that minuscule skeleton is doing inside individual cells in a living animal, and see how it responds and becomes addicted to its environment as diseases such as progress."

The mouse is the latest in a growing canon of groundbreaking biosensor mice developed by the Timpson and Anderson labs, including a biosensor mouse that makes it possible to watch in real time as pancreatic cancer cells prepare to spread beyond the primary tumour. The new biosensor mouse has just been published in the journal Cell Reports.

The mouse contains a fluorescent version of a protein called RhoA, which controls the shape of the cell's skeleton. RhoA is thought be particularly important in "mechanosensing", the process by which cells remodel their own skeleton in response to the softness or rigidity of their surrounding environment.

For this reason, RhoA and its signalling pathway within cells is becoming an attractive new drug target in cancer.

"We're particularly interested in RhoA because it gives us a readout of how cells reorganise themselves as their environment alters, and we know that the cell's immediate environs are crucial in cancer, where a 'stiffer' tumour environment promotes growth and tumour spreading," Anderson said. "Biosensors such as this one also give us the ability to sense where and when drugs hit their targets, which is important for discovering new drugs.

"We also know that forces acting on the cell are crucial in normal tissue such as bone, where cells called osteocytes sense and respond to weight-bearing exercise."

RhoA oscillates rapidly between two states, active and inactive, in response to chemical and physical cues in the environment.

When RhoA is active, the biosensor glows blue-green; when inactive, the biosensor glows red.

Using sophisticated intravital imaging technology, the researchers can watch where RhoA is, and measure how its activity changes, in any organ in the body.

Using the biosensor mouse, the researchers were able to explore the progression of breast cancer and pancreatic cancer in detail.

"We've been able to watch RhoA through the entire process of pancreatic cancer – from early disease, right through to fully developed cancer and then to metastasis, when the cancer spreads beyond the pancreas to the liver," said Timson, a UNSW conjoint senior lecturer. "And what we see is that RhoA switches off and on depending on the organ or stage of disease – this knowledge could be key in helping to guide the timing of new drug schedules and interventions for this aggressive disease.

"We've also visualised the whole cycle of mammary development and watched how cells change during the progression of breast cancer."

The researchers went on to show that the activity of anticancer drugs could be readily assessed in the biosensor mouse.

"This technology allows us to monitor drug activity in cancers in living tissue. And the readout from the mouse is readily interpretable. It's almost like a traffic light – the biosensor molecule is one colour when the cancer's been effectively attacked, and another if it hasn't," Timson said.

Beyond the cancer findings, the research team investigated the activity of RhoA in a range of healthy tissues – including bone and the immune system. These studies were conducted in close collaboration with researchers in Garvan's Bone Biology and Immunology Divisions.

"In the bone work in particular, we've seen things that have never been visualised before – deep inside the cells in living bone," Timpson said.

"We've been able to watch RhoA activity in the small protrusions that extend out from osteocytes (a type of bone cell), and to see what happens when a force is applied – just as it would be during weight-bearing exercise.

"Remarkably, we can see clear colour differences between protrusions that extend in different directions – so we think that the protrusions, through RhoA, are giving the cell feedback on which direction a force is coming from. We think that, in the future, the biosensor mouse could aid our understanding of how weight-bearing exercise could impact on osteoporosis and other bone disorders."

Timpson emphasised that the new biosensor mouse, and others created by the team, were available to researchers worldwide.

"I'm a firm believer that we all benefit when next-generation research tools are used by researchers in different specialties and different parts of the world," he said.

"There are already a number of groups worldwide that are driving new understanding of a range of cancers through these mice – and we'd love to work with others to advance understanding, and ultimately to uncover new therapeutic approaches to ."

Explore further: A versatile mouse that can teach us about many diseases and drugs

More information: Max Nobis et al. A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.09.022

Related Stories

A versatile mouse that can teach us about many diseases and drugs

March 13, 2014
Scientists from the UK and Australia have created a mouse that expresses a fluorescing 'biosensor' in every cell of its body, allowing diseased cells and drugs to be tracked and evaluated in real time and in three dimensions.

How deep can a cell sense

September 20, 2017
National University of Singapore researchers discovered that mechanical cues from the porous microenvironment of the bone matrix could affect the proliferation of cancer cells.

Stress may switch on bone 'mets'

August 10, 2017
Stress stimulates the formation of blood vessels in bone and may help breast cancer cells to invade this organ.

How to wake a sleeping cancer cell—and why you might want to

December 3, 2015
Cancer cells that lie 'snoozing' in the skeleton can be awakened - or left to slumber on - by changes in the bone that surrounds them, Australian scientists have shown. In a world first, researchers from the Garvan Institute ...

New bone-in technique tests therapies for breast cancer metastasis

April 21, 2017
A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. The study appears ...

Study identifies essential molecule in formation of differentiated blood cells

October 7, 2013
New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood diseases ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.